KIC
NVS icon

Kensington Investment Counsel’s Novartis NVS Stock Holding History

Kensington Investment Counsel’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Sell
8,470
-277
-3% -$42.5K 0.62% 41
2025
Q4 		$1.21M Hold
8,747
– – 0.49% 58
2025
Q3 		$1.12M Sell
8,747
-353
-4% -$43.1K 0.46% 64
2025
Q2 		$1.1M Buy
9,100
+9
+0.1% +$1.01K 0.47% 61
2025
Q1 		$1.01M Sell
9,091
-369
-4% -$39.3K 0.45% 61
2024
Q4 		$921K Hold
9,460
– – 0.38% 70
2024
Q3 		$1.09M Sell
9,460
-1
-0% -$113 0.45% 67
2024
Q2 		$1.01M Sell
9,461
-160
-2% -$16.1K 0.45% 66
2024
Q1 		$931K Sell
9,621
-187
-2% -$19.2K 0.43% 69
2023
Q4 		$990K Buy
9,808
+458
+5% +$44.2K 0.52% 63
2023
Q3 		$952K Sell
9,350
-957
-9% -$97.1K 0.59% 61
2023
Q2 		$1.04M Buy
10,307
+707
+7% +$70.7K 0.66% 58
2023
Q1 		$883K Sell
9,600
-4,190
-30% -$366K 0.67% 58
2022
Q4 		$1.25M Sell
13,790
-486
-3% -$40.9K 0.98% 46
2022
Q3 		$1.08M Buy
14,276
+691
+5% +$57.3K 0.91% 52
2022
Q2 		$1.15M Sell
13,585
-235
-2% -$20.6K 0.98% 45
2022
Q1 		$1.21M Buy
13,820
+656
+5% +$56.8K 0.8% 56
2021
Q4 		$1.15M Buy
+13,164
New +$1.09M 0.67% 70
2021
Q2 		$1.19M Buy
12,994
+495
+4% +$44.1K 0.81% 61
2021
Q1 		$1.07M Buy
12,499
+1,328
+12% +$119K 0.8% 62
2020
Q4 		$1.05M Buy
+11,171
New +$976K 0.87% 60

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kensington Investment Counsel's NVS Position: Q1 2026 in Review

Kensington Investment Counsel reduced its Novartis (NVS) stake by 3.2% in Q1 2026, selling an estimated $42.5K and leaving 8,470 shares worth $1.29M. The position accounts for 0.62% of the portfolio, ranked #41.

Kensington Investment Counsel first reported a position in NVS in Q4 2020 and has held it in 21 quarters since. 1,596 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Kensington Investment Counsel held 8,470 shares of Novartis worth $1.29M as of Q1 2026.
  • Kensington Investment Counsel sold 277 Novartis shares in Q1 2026, an estimated $42.5K.
  • Novartis made up 0.62% of Kensington Investment Counsel's portfolio in Q1 2026, its #41 holding.
  • Kensington Investment Counsel first reported a position in Novartis in Q4 2020 and has held it in 21 quarters since.
  • 1,596 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Kensington Investment Counsel's 13F filing for Q1 2026, filed 19 May 2026.